Pomanda estimates the enterprise value of SKILLS ALLIANCE (PHARMA) LIMITED at £9m based on a Turnover of £32.7m and 0.28x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SKILLS ALLIANCE (PHARMA) LIMITED at £5.2m based on an EBITDA of £1.1m and a 4.89x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SKILLS ALLIANCE (PHARMA) LIMITED at £5.9m based on Net Assets of £4.6m and 1.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Skills Alliance (pharma) LimitedOverview
Skills Alliance (pharma) Limited is a live company located in london, EC2Y 5AJ with a Companies House number of 05079848. It operates in the temporary employment agency activities sector, SIC Code 78200. Founded in March 2004, it's largest shareholder is
project thunder bidco limited
with a 100% stake. Skills Alliance (pharma) Limited is a mature,
large sized company, Pomanda has estimated its turnover at
£32.7m with
high
growth in recent years.
Pomanda's financial health check has awarded Skills Alliance (Pharma) Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 2 areas for improvement. Company Health Check FAQs
Health Rating4.5out of 5
5 Strong
4 Regular
2 Weak
Size
annual sales of £32.7m, make it larger than the average company (£16.2m)
£32.7m - Skills Alliance (pharma) Limited
£16.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 27%, show it is growing at a faster rate (5.9%)
27% - Skills Alliance (pharma) Limited
5.9% - Industry AVG
Production
with a gross margin of 15.7%, this company has a comparable cost of product (18.5%)
15.7% - Skills Alliance (pharma) Limited
18.5% - Industry AVG
Profitability
an operating margin of 3% make it as profitable than the average company (2.6%)
3% - Skills Alliance (pharma) Limited
2.6% - Industry AVG
Employees
with 131 employees, this is above the industry average (56)
131 - Skills Alliance (pharma) Limited
56 - Industry AVG
Pay Structure
on an average salary of £103.8k, the company has a higher pay structure (£52.6k)
£103.8k - Skills Alliance (pharma) Limited
£52.6k - Industry AVG
Efficiency
resulting in sales per employee of £249.6k, this is equally as efficient (£244.8k)
£249.6k - Skills Alliance (pharma) Limited
£244.8k - Industry AVG
Debtor Days
it gets paid by customers after 50 days, this is near the average (45 days)
50 days - Skills Alliance (pharma) Limited
45 days - Industry AVG
Creditor Days
its suppliers are paid after 23 days, this is slower than average (4 days)
23 days - Skills Alliance (pharma) Limited
4 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Skills Alliance (pharma) Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 3 weeks, this is less cash available to meet short term requirements (6 weeks)
3 weeks - Skills Alliance (pharma) Limited
6 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 39.3%, this is a lower level of debt than the average (71.6%)
39.3% - Skills Alliance (pharma) Limited
71.6% - Industry AVG
SKILLS ALLIANCE (PHARMA) LIMITED financials
EXPORT
Skills Alliance (Pharma) Limited's latest turnover from December 2023 is £32.7 million and the company has net assets of £4.6 million. According to their latest financial statements, Skills Alliance (Pharma) Limited has 131 employees and maintains cash reserves of £187.9 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Turnover
32,699,171
31,563,291
21,324,018
16,149,646
20,911,076
22,627,012
22,666,360
20,541,958
11,793,852
16,294,032
12,272,442
17,423,247
12,980,409
9,504,461
Other Income Or Grants
Cost Of Sales
27,571,156
25,225,444
16,665,438
13,566,530
17,321,511
18,682,501
18,691,469
16,991,456
9,741,609
13,395,902
10,065,225
14,367,477
10,681,623
7,678,930
Gross Profit
5,128,015
6,337,847
4,658,580
2,583,116
3,589,565
3,944,511
3,974,891
3,550,502
2,052,243
2,898,130
2,207,217
3,055,769
2,298,785
1,825,531
Admin Expenses
4,142,840
4,096,703
2,317,760
1,730,684
4,274,482
4,159,186
4,553,096
3,672,259
751,085
2,125,931
2,118,382
3,168,219
2,163,758
1,667,314
-8,437
Operating Profit
985,175
2,241,144
2,340,820
852,432
-684,917
-214,675
-578,205
-121,757
1,301,158
772,199
88,835
-112,450
135,027
158,217
8,437
Interest Payable
686
1,258
59,472
50,123
32,522
10,911
Interest Receivable
16
5,147
1,010
414
874
1,510
1,507
1,033
1,640
538
482
634
358
936
838
Pre-Tax Profit
985,191
2,245,605
2,340,572
1,156,904
-743,515
-263,289
-609,220
-131,636
1,302,799
772,737
89,317
-111,816
135,385
159,153
9,275
Tax
-108,750
-487,586
-455,132
-129,984
-260,560
-162,275
-20,543
-35,200
-44,563
-2,597
Profit After Tax
876,441
1,758,019
1,885,440
1,026,920
-743,515
-263,289
-609,220
-131,636
1,042,239
610,462
68,774
-111,816
100,185
114,590
6,678
Dividends Paid
308,500
482,830
160,000
Retained Profit
876,441
1,449,519
1,402,610
866,920
-743,515
-263,289
-609,220
-131,636
1,042,239
610,462
68,774
-111,816
100,185
114,590
6,678
Employee Costs
13,597,834
14,934,360
7,674,992
5,077,878
2,124,839
2,040,311
1,722,013
1,667,740
1,551,255
2,018,987
1,553,677
2,274,918
1,647,726
1,254,391
Number Of Employees
131
122
91
76
49
49
42
41
39
52
40
60
44
35
EBITDA*
1,062,507
2,319,493
2,356,968
870,371
-673,582
-195,347
-561,322
-108,215
1,301,158
782,484
98,938
-97,011
157,654
176,802
26,776
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Tangible Assets
63,456
93,066
33,247
23,754
28,114
23,465
35,753
37,117
25,093
25,093
16,965
27,068
41,052
41,818
49,763
Intangible Assets
263,869
294,611
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
327,325
387,677
33,247
23,754
28,114
23,465
35,753
37,117
25,093
25,093
16,965
27,068
41,052
41,818
49,763
Stock & work in progress
Trade Debtors
4,534,574
4,421,475
3,507,149
2,645,517
2,566,091
3,112,493
3,087,832
2,763,612
1,729,252
1,325,457
766,326
953,592
824,449
624,908
265,206
Group Debtors
2,058,663
Misc Debtors
393,697
268,165
566,793
555,267
818,302
314,393
361,421
418,791
136,019
Cash
187,860
1,286,727
597,858
463,535
91,539
141,568
260,997
341,798
484,281
171,846
43,324
149,356
104,338
39,019
335,290
misc current assets
34,790
total current assets
7,174,794
5,976,367
4,671,800
3,664,319
3,475,932
3,568,454
3,710,250
3,524,201
2,384,342
1,497,303
809,650
1,102,948
928,787
663,927
600,496
total assets
7,502,119
6,364,044
4,705,047
3,688,073
3,504,046
3,591,919
3,746,003
3,561,318
2,409,435
1,522,396
826,615
1,130,016
969,839
705,745
650,259
Bank overdraft
928,502
833,630
651,510
349,159
Bank loan
359,575
616,232
Trade Creditors
1,810,529
863,765
742,917
692,211
613,995
601,717
738,172
574,464
733,223
647,904
1,020,079
748,086
584,177
643,281
Group/Directors Accounts
3,440
269,662
other short term finances
10,648
3,549
hp & lease commitments
other current liabilities
1,131,716
1,357,917
1,321,747
1,499,514
1,877,797
1,329,305
1,265,765
937,919
578,023
total current liabilities
2,945,685
2,491,344
2,434,887
2,811,506
3,420,294
2,764,652
2,655,447
1,861,542
578,023
733,223
647,904
1,020,079
748,086
584,177
643,281
loans
35,803
46,451
hp & lease commitments
Accruals and Deferred Income
other liabilities
11,113
provisions
total long term liabilities
35,803
57,564
total liabilities
2,945,685
2,491,344
2,470,690
2,869,070
3,420,294
2,764,652
2,655,447
1,861,542
578,023
733,223
647,904
1,020,079
748,086
584,177
643,281
net assets
4,556,434
3,872,700
2,234,357
819,003
83,752
827,267
1,090,556
1,699,776
1,831,412
789,173
178,711
109,937
221,753
121,568
6,978
total shareholders funds
4,556,434
3,872,700
2,234,357
819,003
83,752
827,267
1,090,556
1,699,776
1,831,412
789,173
178,711
109,937
221,753
121,568
6,978
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Operating Activities
Operating Profit
985,175
2,241,144
2,340,820
852,432
-684,917
-214,675
-578,205
-121,757
1,301,158
772,199
88,835
-112,450
135,027
158,217
8,437
Depreciation
46,590
65,540
16,148
17,939
11,335
19,328
16,883
13,542
10,285
10,103
15,439
22,627
18,585
18,339
Amortisation
30,742
12,809
Tax
-108,750
-487,586
-455,132
-129,984
-260,560
-162,275
-20,543
-35,200
-44,563
-2,597
Stock
Debtors
2,297,294
615,698
873,158
-183,609
-42,493
-22,367
266,850
1,317,132
539,814
559,131
-187,266
129,143
199,541
359,702
265,206
Creditors
946,764
120,848
50,706
78,216
12,278
-136,455
163,708
574,464
-733,223
85,319
-372,175
271,993
163,909
-59,104
643,281
Accruals and Deferred Income
-226,201
36,170
-177,767
-378,283
548,492
63,540
327,846
359,896
578,023
Deferred Taxes & Provisions
Cash flow from operations
-622,974
1,373,227
901,617
623,929
-70,319
-245,895
-336,618
-490,987
345,584
146,397
-106,514
45,839
86,822
-286,567
402,254
Investing Activities
capital expenditure
-15,984
-7,040
-15,519
-25,566
-18,413
-1,455
-21,861
-10,640
-68,102
Change in Investments
cash flow from investments
-15,984
-7,040
-15,519
-25,566
-18,413
-1,455
-21,861
-10,640
-68,102
Financing Activities
Bank loans
-359,575
-256,657
616,232
Group/Directors Accounts
-266,222
269,662
Other Short Term Loans
-10,648
7,099
3,549
Long term loans
-35,803
-10,648
46,451
Hire Purchase and Lease Commitments
other long term liabilities
-11,113
11,113
share issue
-192,707
188,824
12,744
-131,669
300
interest
16
4,461
-248
414
-58,598
-48,613
-31,015
-9,878
1,640
538
482
634
358
936
838
cash flow from financing
-458,913
56,921
-258,823
546,090
-58,598
-48,613
-31,015
-9,878
1,640
538
482
634
358
936
1,138
cash and cash equivalents
cash
-1,098,867
688,869
134,323
371,996
-50,029
-119,429
-80,801
-142,483
312,435
128,522
-106,032
45,018
65,319
-296,271
335,290
overdraft
-928,502
94,872
182,120
302,351
349,159
change in cash
-1,098,867
688,869
134,323
1,300,498
-144,901
-301,549
-383,152
-491,642
312,435
128,522
-106,032
45,018
65,319
-296,271
335,290
skills alliance (pharma) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for skills alliance (pharma) limited. Get real-time insights into skills alliance (pharma) limited's credit score, group structure and payment trends.
Perform a competitor analysis for skills alliance (pharma) limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other large companies, companies in EC2Y area or any other competitors across 12 key performance metrics.
skills alliance (pharma) limited Ownership
SKILLS ALLIANCE (PHARMA) LIMITED group structure
Skills Alliance (Pharma) Limited has no subsidiary companies.
The sole shareholder of Skills Alliance (Pharma) Limited is Project Thunder Bidco Limited.
project thunder bidco limited
100%
skills alliance (pharma) limited directors
Skills Alliance (Pharma) Limited currently has 6 directors.
The longest serving directors include
Mr Carl Marotta (Feb 2014) and
Mr Christopher Cook (Jul 2022).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 9 charges/mortgages relating to skills alliance (pharma) limited. Currently there are 5 open charges and 4 have been satisfied in the past.
skills alliance (pharma) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SKILLS ALLIANCE (PHARMA) LIMITED. This can take several minutes, an email will notify you when this has completed.
skills alliance (pharma) limitedCompanies House Filings - See Documents
